Edit Entry

Marlene B. Goldman, M.S., Sc.D.

Title(s):
Professor of Obstetrics and Gynecology
Professor of Community and Family Medicine
Vice Chair for Research, Department of Obstetrics and Gynecology

Department(s):
Obstetrics and Gynecology
Community and Family Medicine

Education:
1970 A.B. Colby College, Waterville, ME
1978 M.S. Harvard University, School of Public Health, Boston, MA
1984 Sc.D. Harvard University, School of Public Health, Boston, MA

Programs:
Norris Cotton Cancer Center

Websites:
http://bio-epi.hitchcock.org

Contact Information:

Department of Obstetrics and Gynecology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756

Office: Faulkner, 5M
Phone: 603-653-9304
Fax: 603-650-0906
Email: Marlene.B.Goldman@dartmouth.edu

Asst. Phone: 603-653-9274


Professional Interests:

Dr. Goldman is a reproductive epidemiologist and Director of Clinical Research in the Department of Obstetrics and Gynecology. She specializes in research and teaching related to women's health. Her research program includes several large randomized clinical trials evaluating optimal infertility treatment for younger and older women seeking to conceive and a prospective cohort study investigating the role of preconception nutrition and oxidative stress on implantation and early pregnancy loss. She is senior editor of Women & Health, a comprehensive reference textbook for researchers, teaching faculty, and clinicians now in its second edition.

Grant Information:

2006-2013 Principal Investigator, R01 HD049762, Antioxidant Status, Diet, and Early Pregnancy. NICHD/NIH, $3,171,000.

2009-2011 Principal Investigator, R01 HD049762S1, Antioxidant Status, Diet, and Early Pregnancy, NICHD/NIH, $264,944.

2009-2011, Co-investigator, R21 HD060829, Development of an Infertility Family Registry, NICHD/NIH, PI: Stern.

2009-2011, Co-investigator, R03 HD061867, Decision-making in Pelvic Floor Disorders: Translating Outcomes to Practice, NICHD/NIH, PI: Whiteside.

2003-2011 Co-Investigator, R01 HD44457, Optimal Infertility Therapy RCT: Women 40 and Older. NICHD/NIH, PI: Reindollar, R., $3,195,000.

2000-2008 Co-Investigator, R01 HD38561, Conventional Infertility Therapy vs. Fast Track to IVF. NICHD/NIH, PI: Reindollar, R., $2,720,000.

2003-2006 Principal Investigator, UC1 HS014376, Risk and Recovery in Complex Environments: Labor & Delivery as a Model. AHRQ, $200,000.


Selected Publications:

 

  • Kaser DJ, Goldman MB, Fung JL, Alper MM, Reindollar RH. When is clomiphene or gonadotropin intrauterine insemination futile? Fertil Steril 2014 (view details on MedLine)

  • Goldman MB, Thornton KL, Ryley D, Alper MM, Fung JL, Hornstein MD, Reindollar RH. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril 2014;101:1574-1581. (view details on MedLine)

  • Ruder EH, Hartman TJ, Reindollar RH, Goldman MB. Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility. Fertil Steril 2014;101:759-766. (view details on MedLine)

  • Reindollar RH, Regan MM, Neumann PJ, Levine BS, Thornton KL, Alper MM, Goldman MB. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril 2010;94:888-899. (view details on MedLine)

  • Reindollar RH, Goldman MB. Gonadotropin therapy: a 20th century relic. Fertil Steril 2012;97:813-818. (view details on MedLine)

  • Goldman MB, Troisi R, Rexrode KM. Women and Health (2nd edition) http://booksite.elsevier.com/9780123849786